AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,815,000 | +5.2% | 402,081 | -26.0% | 0.01% | 0.0% |
| Q3 2014 | $6,478,000 | +128.4% | 543,481 | +8.1% | 0.01% | +120.0% |
| Q2 2014 | $2,836,000 | +45.1% | 502,881 | -5.5% | 0.01% | +25.0% |
| Q1 2014 | $1,954,000 | +16.4% | 532,381 | +6.6% | 0.00% | +33.3% |
| Q4 2013 | $1,678,000 | -9.4% | 499,481 | +14.3% | 0.00% | -25.0% |
| Q3 2013 | $1,853,000 | +1.8% | 437,100 | +10.4% | 0.00% | 0.0% |
| Q2 2013 | $1,821,000 | – | 395,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,436,053 | $10,329,000 | 1.78% |
| GREAT POINT PARTNERS LLC | 200,000 | $846,000 | 0.59% |
| Tekla Capital Management LLC | 960,000 | $4,070,000 | 0.45% |
| Artal Group S.A. | 3,100,000 | $13,113,000 | 0.43% |
| Baker Brothers Advisors | 4,428,591 | $18,733,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,446,839 | $6,120,000 | 0.24% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,545 | $408,000 | 0.21% |
| EAM Investors, LLC | 236,609 | $1,003,000 | 0.20% |
| ASCEND CAPITAL, LLC | 979,370 | $4,143,000 | 0.15% |
| Orbimed Advisors | 1,863,400 | $7,882,000 | 0.14% |